Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 3, 2005, Pages 673-678

  Ungerstedt, J S ^a   Sowa, Y ^a,c   Xu, W S ^a   Shao, Y ^a   Dokmanovic, M ^a   Perez, G ^a   Ngo, L ^a   Holmgren, A ^b   Jiang, X ^a   Marks, P A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Apoptosis; MS 275; Reactive oxygen species; Suberoylanilde hydroxamic acid

Indexed keywords

ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; CASPASE; CASPASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; DIMETHYL SULFOXIDE; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; HISTONE H4; N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; THIOREDOXIN; VORINOSTAT;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; STRESS;

APOPTOSIS; BENZAMIDES; CASPASES; CELL LINE, TRANSFORMED; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; NEOPLASMS; PYRIDINES; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; THIOREDOXIN;

EID: 20044390016     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0408732102     Document Type: Article

References (46)

1. Thornberry, N. A. & Lazebnik, Y. (1998) Science 281, 1312-1316.
2. Jiang, X. & Wang, X. (2004) Annu. Rev. Biochem. 73, 87-106.
3. Rosato, R. R., Almenara, J. A. & Grant, S. (2003) Cancer Res. 63, 3637-3645.
4. Ruefli, A. A., Ausserlechner, M. J., Bernhard, D., Sutton, V. R., Tainton, K. M., Kofler, R., Smyth, M. J. & Johnstone, R. W. (2001) Proc. Natl. Acad. Sci. USA 98, 10833-10838.
5. Laurent, T. C., Moore, E. C. & Reichard, P. (1964) J. Biol. Chem. 239, 3436-3444.
6. Holmgren, A. (1989) J. Biol. Chem. 264, 13963-13966.
7. Arner, E. S. & Holmgren, A. (2000) Eur. J. Biochem. 267, 6102-6109.
8. Kelly, W. K., Richon, V. M., O'Connor, O., Curley, T., MacGregor-Curtelli, B., Tong, W., Klang, M., Schwanz, L., Richardson, S., Rosa, E., et al. (2003) Clin. Cancer Res. 9, 3578-3588.
9. Kelly, W. K., O'Connor, O. A. & Marks, P. (2002) Expert. Opin. Invest. Drugs 11, 1695-1713.
10. Piekarz, R. & Bates, S. (2004) Curr. Pharm. Des. 10, 2289-2298.
11. Qiu, L., Kelso, M. J., Hansen, C., West, M. L., Fairlie, D. P. & Parsons, P. G. (1999) Br. J. Cancer 80, 1252-1258.
12. Butler, L. M., Agus, D. B., Scher, H. I., Higgins, B., Rose, A., Cordon-Cardo, C., Thaler, H. T., Rifkind, R. A., Marks, P. A. & Richon, V. M. (2000) Cancer Res. 60, 5165-5170.
13. Atadja, P., Gao, L., Kwon, P., Trogani, N., Walker, H., Hsu, M., Yeleswarapu, L., Chandramouli, N., Perez, L., Versace, R., et al. (2004) Cancer Res. 64, 689-695.
14. Marks, P. A., Richon, V. M., Miller, T. & Kelly, W. K. (2004) Adv. Cancer Res. 91, 137-168.
15. de Ruijter, A. J., van Gennip, A. H., Caron, H. N., Kemp, S. & van Kuilenburg. A. B. (2003) Biochem. J. 370, 737-749.
16. Johnstone, R. W. & Licht, J. D. (2003) Cancer Cell 4, 13-18.
17. Marks, P., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T. & Kelly, W. K. (2001) Nat. Rev. Cancer 1, 194-202.
18. Cress, W. D. & Seto, E. (2000) J. Cell Physiol. 184, 1-16.
19. Jones, P. A. & Baylin, S. B. (2002) Nat. Rev. Genet. 3, 415-428.
20. Khochbin, S., Verdel, A., Lemercier, C. & Seigneurin-Berny, D. (2001) Curr. Opin. Genet. Dev. 11, 162-166.
21. Lehrmann, H., Pritchard, L. L. & Harel-Bellan, A. (2002) Adv. Cancer Res. 86, 41-65.
22. Miller, T. (2004) Expert Opin. Therapeutic Patents 14, 791-804.
23. Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A. & Marks, P. A. (1996) Proc. Natl. Acad. Sci. USA 93, 5705-5708.
24. Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R. & Pavletich, N. P. (1999) Nature 401, 188-193.
25. Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., Ando, T., Suzuki, T., Tsuruo, T. & Nakanishi, O. (1999) Proc. Natl. Acad. Sci. USA 96, 4592-4597.
26. Peart, M. J., Tainton, K. M., Ruefli, A. A., Dear, A. E., Sedelies, K. A., O'Reilly, L. A., Waterhouse, N. J., Trapani, J. A. & Johnstone, R. W. (2003) Cancer Res. 63, 4460-4471.
27. Budihardjo, I., Oliver, H., Lutter, M., Luo, X. & Wang, X. (1999) Annu. Rev. Cell Dev. Biol. 15, 269-290.
28. Liu, X., Kim, C. N., Yang, J., Jemmerson, R. & Wang, X. (1996) Cell 86, 147-157.
29. Yokomizo, A., Ono, M., Nanri, H., Makino, Y., Ohga, T., Wada, M., Okamoto, T., Yodoi, J., Kuwano, M. & Kohno, K. (1995) Cancer Res. 55, 4293-4296.
30. Sasada, T., Iwata, S., Sato, N., Kitaoka, Y., Hirota, K., Nakamura, K., Nishiyama, A., Taniguchi, Y., Takabayashi, A. & Yodoi, J. (1996) J. Clin. Invest. 97, 2268-2276.
31. Rundlof, A. K. & Arner, E. S. (2004) Antioxid. Redox. Signal 6, 41-52.
32. Nakamura, H. (2004) Antioxid. Redox. Signal 6, 15-17.
33. Shao, L., Diccianni, M. B., Tanaka, T., Gribi, R., Yu, A. L., Pullen, J. D., Camilla, B. M. & Yu, J. (2001) Cancer Res. 61, 7333-7338.
34. Butler, L. M., Zhou, X., Xu, W.-S., Scher, H. I., Rifkind, R. A., Marks, P. A. & Richon, V. M. (2002) Proc. Natl. Acad. Sci. USA 99, 11700-11705.
35. Gui, C. Y., Ngo, L., Xu, W. S., Richon, V. M. & Marks, P. A. (2004) Proc. Natl. Acad. Sci. USA 101, 1241-1246.
36. Richon, V. M., Zhou, X., Secrist, J. P., Cordon-Cardo, C., Kelly, W. K., Drobnjak, M. & Marks, P. A. (2004) Methods Enzymol. 376, 199-205.
37. Arner, E. S., Zhong, L. & Holmgren, A. (1999) Methods Enzymol. 300, 226-239.
38. Richon, V. M., Sandhoff, T. W., Rifkind, R. A. & Marks, P. A. (2000) Proc. Natl. Acad. Sci. USA 97, 10014-10019.
39. Jiang, X., Kim, H. E., Shu, H., Zhao, Y., Zhang, H., Kofron, J., Donnelly, J., Burns, D., Ng, S. C., Rosenberg, S. & Wang, X. (2003) Science 299, 223-226.
40. Holmgren, A. (1995) Structure (London) 3, 239-243.
41. Shao, Y., Gao, Z., Marks, P. A. & Jiang, X. (2004) Proc. Natl. Acad. Sci. USA 101, 18030-18035.
42. Okada, H. & Mak, T. W. (2004) Nat. Rev. Cancer 4, 592-603.
43. Nakamura. H., Masutani, H., Tagaya, Y., Yamauchi, A., Inamoto, T., Nanbu, Y., Fujii, S., Ozawa, K. & Yodoi, J. (1992) Cancer 69, 2091-2097.
44. Yu, C., Subler, M., Rahmani. M., Reese, E., Krystal, G., Conrad, D., Dent, P. & Grant, S. (2003) Cancer Biol. Ther. 2, 544-551.
45. Powis, G., Muslacich, D. & Coon, A. (2000) Free Radical Biol. Med. 29, 312-322.
46. Baker, A., Payne, C. M., Briehl, M. M. & Powis, G. (1997) Cancer Res. 57, 5162-5167.